Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 43 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

43 other filings hidden
DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
Jan. 12, 2018 ABUS P 664,000 $100.00 $66,400,000 1,164,000 Indirect +132.80% Acquired -95.6% (price as of 2026-10-05)
Oct. 16, 2017 ABUS P 500,000 $100.00 $50,000,000 500,000 Indirect · Acquired -95.6% (price as of 2026-10-05)
Sept. 15, 2016 SCYX P 40,000 $2.94 $117,600 60,000 Direct +200.00% Acquired -97.9% (price as of 2026-10-05)
June 24, 2016 SCYX P 20,000 $2.39 $47,800 20,000 Direct · Acquired -97.4% (price as of 2026-10-05)
June 24, 2016 SCYX P 9,000 $0.02 $180 9,000 Direct · Acquired 206.3% (price as of 2026-10-05)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
June 30, 2026 ALMS Stock Option (Right to Buy) Common Stock (15,528) $28.14 June 29, 2036 15,528 Acquired
June 11, 2026 RCUS Stock Option (Right to Buy) Stock Option (Rights to Buy) (16,900) $23.30 June 10, 2036 16,900 Acquired
June 3, 2026 XENE Restricted Share Units Common Shares (1,593) $0.00 · 1,593 Acquired
June 3, 2026 XENE Share Option (Right to Buy) Common Shares (10,507) $53.46 June 2, 2036 10,507 Acquired
June 1, 2026 XENE Restricted Share Units Common Shares (2,645) · · 2,645 Disposed
July 30, 2025 ALMS Stock Option (Right to Buy) Common Stock (49,800) $4.10 July 29, 2035 49,800 Acquired
June 10, 2025 RCUS Stock Option (Right to Buy) Common Stock (38,300) $10.02 June 9, 2035 38,300 Acquired
May 21, 2025 ALMS Stock Option (Right to Buy) [F3] Class A Common Stock (44,364) · June 6, 2034 44,364 Acquired
May 21, 2025 ALMS Stock Option (Right to Buy) [F6] Class A Common Stock (11,189) · May 3, 2033 11,189 Acquired
May 21, 2025 ALMS Stock Option (Right to Buy) [F7] Class A Common Stock (41,499) · Nov. 20, 2032 41,499 Acquired
May 21, 2025 ALMS Stock Option (Right to Buy) [F8] Class A Common Stock (13,804) · Nov. 20, 2032 13,804 Acquired
May 21, 2025 ALMS Stock Option (Right to Buy) [F9] Class A Common Stock (19,528) · July 25, 2031 19,528 Acquired
July 1, 2024 ALMS Stock Option (Right to Buy) Class A Common Stock (38,000) $16.00 June 26, 2034 38,000 Disposed
July 1, 2024 ALMS Stock Option (Right to Buy) Common Stock (38,000) $16.00 June 26, 2034 38,000 Acquired
June 27, 2024 ALMS Stock Option (Right to Buy) Class A Common Stock (38,000) $16.00 June 26, 2034 38,000 Acquired
June 6, 2024 RCUS Stock Option (Right to Buy) Common Stock (24,000) $15.90 June 5, 2034 24,000 Acquired
June 5, 2024 XENE Stock Option (Right to Buy) Common Shares (15,542) $38.16 June 4, 2034 15,542 Acquired
June 15, 2023 RCUS Stock Option (Right to Buy) Common Stock (19,500) $19.60 June 14, 2033 19,500 Acquired
June 2, 2023 XENE Stock Option (Right to Buy) Common Shares (18,475) $38.96 June 1, 2033 18,475 Acquired
June 28, 2022 XENE Stock Option (Right to Buy) Common Shares (18,000) $30.11 June 27, 2032 18,000 Acquired
June 14, 2022 RCUS Stock Option (Right to Buy) Common Stock (16,800) $20.62 June 13, 2032 16,800 Acquired
June 3, 2021 RCUS Stock Option (Right to Buy) Common Stock (14,100) $24.79 June 2, 2031 14,100 Acquired
June 3, 2021 XENE Stock Option (Right to Buy) Common Shares (10,000) $18.56 June 2, 2031 10,000 Acquired
Nov. 5, 2020 XENE Stock Option (Right to Buy) Common Shares (20,000) $11.85 Nov. 4, 2030 20,000 Acquired
June 4, 2020 RCUS Stock Option (Right to Buy) Common Stock (14,000) $30.05 June 3, 2030 14,000 Acquired
Dec. 10, 2019 RCUS Stock Option (right to buy) Common Stock (50,000) $8.55 Dec. 9, 2029 50,000 Acquired
Jan. 2, 2019 SCYX Stock Option (right to buy) Common Stock (22,500) $0.54 Jan. 1, 2029 22,500 Acquired
Jan. 12, 2018 ABUS Series A Participating Convertible Preferred Shares Common shares, no par value · Oct. 16, 2021 664,000 Acquired
Jan. 2, 2018 SCYX Stock Option (right to buy) Common Stock (19,989) $2.28 Jan. 1, 2028 19,989 Acquired
Oct. 16, 2017 ABUS Series A Participating Convertible Preferred Shares Common shares, no par value · Oct. 16, 2021 500,000 Acquired
June 20, 2017 RCKT Stock Options (Right to Buy) Common Stock (45,000) $1.80 June 19, 2027 45,000 Acquired
Jan. 3, 2017 SCYX Stock Option (right to buy) Common Stock (14,499) $3.40 Jan. 3, 2027 14,499 Acquired
Aug. 17, 2016 RCKT Stock Options (Right to Buy) Common Stock (24,000) $6.91 Aug. 17, 2026 24,000 Acquired
June 24, 2016 SCYX Common Stock Warrant (right to buy) Common Stock (9,000) $3.00 June 23, 2021 9,000 Acquired
June 2, 2016 SCYX Stock Option (right to buy) Common Stock (8,800) $3.98 June 1, 2026 8,800 Acquired
Sept. 24, 2015 SCYX Stock Option (right to buy) Common Stock (11,700) $6.89 Sept. 23, 2025 11,700 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 8 holdings

07

Securities held when first becoming an insider, per SEC Form 3.

DateTickerSecuritySharesOwnership
Oct. 1, 2021 ROIV Stock Option (Right to Buy)→ Common Shares (170,167) 170,167 Direct
Oct. 1, 2021 ROIV Stock Option (Right to Buy)→ Common Shares (109,732) 109,732 Direct
Oct. 1, 2021 ROIV Stock Option (Right to Buy)→ Common Shares (109,732) 109,732 Direct
Oct. 1, 2021 ROIV Stock Option (Right to Buy)→ Common Shares (109,732) 109,732 Direct
Oct. 1, 2021 ROIV Stock Option (Right to Buy)→ Common Shares (109,732) 109,732 Direct
Nov. 5, 2020 XENE No securities are beneficially owned 0 Indirect
Nov. 5, 2020 XENE No securities are beneficially owned→ N/A [F1] · Direct
Oct. 19, 2016 ABUS Common Shares, no par value 16,013,540 Indirect